MorphoSys AG buy dasgutemorchen
Summary
This prediction ended on 14.07.10 with a price of €15.03. The prediction for MorphoSys AG disappointed with a performance of -13.22%. dasgutemorchen has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | -1.476% | -1.476% | 262.181% | -16.395% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by dasgutemorchen for this prediction
In the thread Morphosys AG diskutieren
gut aufgestellte Kooperationen
MorphoSys + Wacker u.a. schaffen sich mit Forschung u. Technologie deutliche Marktvorteile. Außerdem besitzt MorphoS genug cash um auch langfristig zu planen. Charttechnisch ebenso klares Kaufsignal auch für zittrige Hände - f. mich klarer Kauf "ohne" Risiko.